
TWO CASES OF ALLELES WITH COMPLEX GENOTYPES
AMONG CYSTIC FIBROSIS PATIENTS FROM CROATIA
Tanacković G1, Barišić I2, Knežević J1, Pavelić J1,* *Corresponding Author: Professor Dr. Jasminka Pavelić, Division of Molecular Medicine, Rudjer Bošković Institute, Bijenička cesta 54, HR-10002 Zagreb, Croatia; Tel: +385-1-4560-926; Fax: +385-1-456-1010; E-mail: jpavelic@rudjer.irb.hr page: 3
|
INTRODUCTION
Cystic fibrosis (CS) is a Mendelian recessive disorder and only appears when both alleles are mutated. The gene responsible for cystic fibrosis is Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR), and codes for chloride channels in the apical membrane of epithelial cells. The protein consists of two sets of six membrane spanning segments, two nucleotide-binding domains (NBD1 and NBD2) and a regulatory domain (R) [1]. More than 1000 different mutations and 200 polymorphisms have been reported in this gene (www.genet. sickkids.on.ca), making CF one of the best examples of allelic heterogeneity in human genetic diseases.
Alleles with two mutations (double mutant alleles) can also be found, as well as so-called complex genotypes consisting of mutation and polymorphism on the same allele [2].
Different mutations in protein regions have different effects on its function. However, not only mutations can change the protein function. For example, a polymorphic Tn locus, with five or seven T-nucleotide repeats, in front of exon 9, can cause a downsynthesis of a full-length CFTR protein [3,4]. Therefore, it can be concluded that polymorphisms, in combination with mutations, may also be responsible for variation in CF phenotype expression [2].
In this paper we report on two different alleles (found in two unrelated patients from Croatia), where the same mutation was combined with different polymorphisms. The polymorphism F508C is represented as a missense substitution T®G at nucleotide position 1655, which changes the protein’s phenylalanine residue to cysteine (protein function is retained). The polymorphism P1290P is characterized by the substitution of nucleotide A with G in the second codon (out of two) for phenylalanine in exon 20 (amino acid position 1290).
__________________________________________
1 Division of Molecular Medicine, Rudjer Bošković Institute, Zagreb, Croatia
2 Department of Pediatrics, Children's Hospital, Zagreb, Croatia
|
|
|
|



 |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|
|